Chinook Tyee Industry Ltd Share Price Toronto S.E.
Equities
GBI.H
CA16961T2083
Pharmaceuticals
Sales 2022 | - | Sales 2023 | - | Capitalization | 3L 2L 1.97Cr |
---|---|---|---|---|---|
Net income 2022 | -10L -7L -6.1Cr | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
Net Debt 2022 | 31.49L 23.06L 19Cr | Net Debt 2023 | 27.69L 20.28L 17Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-1.08
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.11% |
Managers | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/14 |
Director/Board Member | 72 | 05/18/05 | |
Investor Relations Contact | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 14/12/14 |
Director/Board Member | 72 | 05/18/05 | |
Frank Otto
BRD | Director/Board Member | - | 11/22/11 |
1st Jan change | Capi. | |
---|---|---|
+43.31% | 629.11Cr | |
-16.99% | 442.21Cr | |
+6.39% | 329.72Cr | |
-13.10% | 305.4Cr | |
-4.17% | 246.81Cr | |
+45.47% | 194.01Cr | |
-9.11% | 165.96Cr | |
-2.09% | 161.36Cr | |
-12.50% | 154.05Cr |